BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16537173)

  • 1. A method for purification and viral inactivation of human placenta hemoglobin.
    Li T; Yu R; Zhang HH; Wang H; Liang WG; Yang XM; Yang CM
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(2):175-88. PubMed ID: 16537173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Purification and viral inactivation of hemoglobin from human placenta blood].
    Li T; Zhang H; Wang H; Yu R; Yang C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):640-4. PubMed ID: 16856406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete deoxygenation from a hemoglobin solution by an electrochemical method and heat treatment for virus inactivation.
    Huang Y; Takeoka S; Sakai H; Abe H; Hirayama J; Ikebuchi K; Ikeda H; Tsuchida E
    Biotechnol Prog; 2002; 18(1):101-7. PubMed ID: 11822907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DBBF modified human placenta hemoglobin through the alpha chains.
    Huang L; Wang B; Wang X; Liang WG; Yang CM
    Artif Cells Blood Substit Immobil Biotechnol; 2008; 36(2):156-65. PubMed ID: 18437592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of concentrated hemoglobin using organic solvent and heat treatment.
    Sakai H; Takeoka S; Yokohama H; Seino Y; Nishide H; Tsuchida E
    Protein Expr Purif; 1993 Dec; 4(6):563-9. PubMed ID: 8286954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and viral inactivation of hemoglobin from human placenta blood.
    Li F; Zhang H; Wang J; Yang C
    Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(2):57-60. PubMed ID: 19229697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of human hemoglobin: effect of the hemolysis conditions.
    Andrade CT; Barros LA; Lima MC; Azero EG
    Int J Biol Macromol; 2004 Aug; 34(4):233-40. PubMed ID: 15374679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged oxygen-carrying ability of hemoglobin vesicles by coencapsulation of catalase in vivo.
    Teramura Y; Kanazawa H; Sakai H; Takeoka S; Tsuchida E
    Bioconjug Chem; 2003; 14(6):1171-6. PubMed ID: 14624631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple and improved method for extraction of phospholipids from hemoglobin solutions.
    Yan KP; Hao J; Dan N; Chen C
    Artif Cells Blood Substit Immobil Biotechnol; 2008; 36(1):19-33. PubMed ID: 18293158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of freeze-drying process on polymerized human placenta hemoglobin].
    Zhao L; Li S; Li F; Wang J; Yang C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Oct; 30(5):1052-7. PubMed ID: 24459969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemoglobin vesicles containing methemoglobin and L-tyrosine to suppress methemoglobin formation in vitro and in vivo.
    Atoji T; Aihara M; Sakai H; Tsuchida E; Takeoka S
    Bioconjug Chem; 2006; 17(5):1241-5. PubMed ID: 16984134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The properties research of polymerized human placenta hemoglobin before and after lyophilization.
    Zhao L; Zhou W; Wang J; Li S; Chen G; Liu J; Yang C
    Artif Cells Nanomed Biotechnol; 2014 Apr; 42(2):78-82. PubMed ID: 24295107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Freeze-drying of oxygen-carrying substances and storage stability of the freeze-dried solids].
    Wang Z; Li F; Zhang H; Yu R; Yang C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Jun; 25(3):678-81, 693. PubMed ID: 18693455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring circulating blood volume using infused hemoglobin-based oxygen carrier (oxyglobin) as an indicator: verification in a canine hypovolemia model.
    Jahr JS; Lurie F; Bezdikian V; Driessen B; Gunther RA
    Am J Ther; 2008; 15(2):98-101. PubMed ID: 18356627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of parvovirus B19 during STIM-4 vapor heat treatment of three coagulation factor concentrates.
    Berting A; Modrof J; Unger U; Gessner M; Klotz A; Poelsler G; Kreil TR
    Transfusion; 2008 Jun; 48(6):1220-6. PubMed ID: 18410254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanism underlying B19 virus inactivation and comparison to other parvoviruses.
    Mani B; Gerber M; Lieby P; Boschetti N; Kempf C; Ros C
    Transfusion; 2007 Oct; 47(10):1765-74. PubMed ID: 17880601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of manufacturing process parameters on virus inactivation by dry heat treatment at 80 degrees C in factor VIII.
    Roberts PL; Dunkerley C; McAuley A; Winkelman L
    Vox Sang; 2007 Jan; 92(1):56-63. PubMed ID: 17181591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability of parvovirus B19 to inactivation by liquid heating in plasma products.
    Hattori S; Yunoki M; Tsujikawa M; Urayama T; Tachibana Y; Yamamoto I; Yamamoto S; Ikuta K
    Vox Sang; 2007 Feb; 92(2):121-4. PubMed ID: 17298573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEGylation promotes hemoglobin tetramer dissociation.
    Caccia D; Ronda L; Frassi R; Perrella M; Del Favero E; Bruno S; Pioselli B; Abbruzzetti S; Viappiani C; Mozzarelli A
    Bioconjug Chem; 2009 Jul; 20(7):1356-66. PubMed ID: 19534518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of methemoglobin (MetHb) formation and hemin loss in the pro-oxidant activity of fish hemoglobins.
    Maestre R; Pazos M; Medina I
    J Agric Food Chem; 2009 Aug; 57(15):7013-21. PubMed ID: 19722582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.